Eli Lilly $1.3B Collaboration with Boston based Superluminal to develop Small Molecule Therapy for Cardiometabolic and Obesity.
Boston, MA – August 14, 2025 – Superluminal Medicines, a pioneering drug discovery company integrating artificial intelligence, machine learning,...
